Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H34O5 |
Molecular Weight | 390.5131 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C5=CC(=O)OC5)[C@@]1(C)CC[C@H](O)C2
InChI
InChIKey=SHIBSTMRCDJXLN-KCZCNTNESA-N
InChI=1S/C23H34O5/c1-21-7-5-15(24)10-14(21)3-4-17-18(21)11-19(25)22(2)16(6-8-23(17,22)27)13-9-20(26)28-12-13/h9,14-19,24-25,27H,3-8,10-12H2,1-2H3/t14-,15+,16-,17-,18+,19-,21+,22+,23+/m1/s1
Molecular Formula | C23H34O5 |
Molecular Weight | 390.5131 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Digoxigenin is a 390.5 Da steroid expressed in heart, kidney, liver, adrenal gland, cerebral cortex, lung and placental tissues; Antibodies to Digoxigenin can be used to study tumor development. Bispecific antibodies (bsAbs) that bind to both tumor specific antigens on the cell surface and to haptens such as digoxigenin (Dig) can direct digoxigeninylated payloads to tumor cells. Digoxigenin is widely used as a method for generating non-radioactive probes, and is an alternative to biotinylation.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL614056 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16309315 |
317.5 nM [IC50] | ||
Target ID: CHEMBL387 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16309315 |
507.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
One-, two-, and three-color whole-mount in situ hybridization to Drosophila embryos. | 2001 Apr |
|
Nonradioactive in situ hybridization to xenopus tissue sections. | 2001 Apr |
|
A system to enhance the sensitivity of digoxigenin-labelled probe: detection of B19 DNA in serum samples. | 2001 Apr |
|
[Molecular diagnosis of fragile X syndrome with polymerase chain reaction: application of a diagnostic protocol in 50 families from northern Spain]. | 2001 Apr |
|
Non-radioactive digoxigenin DNA labeling and immunologic detection of HSV PCR products. | 2001 Dec |
|
[Pathogenecity and replication of transfusion transmitted virus in liver tissue by in situ hybridization]. | 2001 Jan |
|
Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction. | 2001 Jun |
|
Differentiation of porcine circovirus 1 and 2 in formalin-fixed, paraffin-wax-embedded tissues from pigs with postweaning multisystemic wasting syndrome by in-situ hybridisation. | 2001 Jun |
|
Nonradioactive detection of the common Connexin 26 167delT and 35delG mutations and frequencies among Ashkenazi Jews. | 2001 Jun |
|
Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS). | 2001 Jun |
|
Cellular localization of BM88 mRNA in paraffin-embedded rat brain sections by combined immunohistochemistry and non-radioactive in situ hybridization. | 2001 Jun |
|
Developmental patterns of ceramide glucosyltransferase (GlcT-1) expression in the mouse: in situ hybridization using DIG-labeled RNA probes. | 2001 Jun 30 |
|
[Development of donor cells in chicken-duck chimeric embryos]. | 2001 Nov |
|
Quantification of Escherichia coli genomic DNA contamination in recombinant protein preparations by polymerase chain reaction and affinity-based collection. | 2001 Sep 1 |
|
Identification and preliminary characterization of mouse Adam33. | 2002 |
|
Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. | 2002 Apr 22 |
|
Identification to the species level of the plant pathogens Phytophthora and Pythium by using unique sequences of the ITS1 region of ribosomal DNA as capture probes for PCR ELISA. | 2002 Feb 5 |
|
Connective tissue growth factor is directly related to liver fibrosis. | 2002 Jan-Feb |
|
Molecular genetic evaluation of fluorescence diagnosis in bladder cancer. | 2002 Mar |
|
Down-regulation of Lsm1 is involved in human prostate cancer progression. | 2002 Mar 18 |
|
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. | 2002 Mar 18 |
|
Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers. | 2002 Mar 18 |
|
Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization. | 2002 Mar 22 |
|
Effect of developmental lead exposure on the expression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal rats by digoxigenin-labeled in situ hybridization histochemistry. | 2002 Mar-Apr |
|
Cysteine-free mutant of aequorin as a photolabel in immunoassay development. | 2002 Mar-Apr |
|
Conjugates bearing multiple formyl-methionyl peptides display enhanced binding to but not activation of phagocytic cells. | 2002 Mar-Apr |
|
High-sensitivity hybridization assay for quantitation of residual E. coli DNA. | 2002 May |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9016315
Cellular uptake and intracellular distribution of liposomal digoxigenin-labeled oligodeoxynucleotides (ODNs) at several concentrations (0.1, 0.2, an 1.0 uM) in CaSki cells were studied.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:40:58 GMT 2023
by
admin
on
Fri Dec 15 19:40:58 GMT 2023
|
Record UNII |
NQ1SX9LNAU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1672-46-4
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY | |||
|
D004076
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY | |||
|
DTXSID6051778
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY | |||
|
7108
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY | |||
|
15478
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY | |||
|
216-806-2
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY | |||
|
DB03671
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY | |||
|
DIGOXIGENIN
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY | |||
|
145797
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY | |||
|
m4455
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY | Merck Index | ||
|
NQ1SX9LNAU
Created by
admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|